Emerging Pathogens Program News Today

“We cannot ignore the evidence” that Omicron may be evolving into a more severe form of itself, one researcher told Fortune.

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains why this variant did not cause a widespread surge as previously feared.

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced an

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced an

EG.5, the fast-spreading COVID subvariant, is now circulating in Canada as health officials across the world grapple to figure out its potential impact.

A new coronavirus variant, EG.5, now accounts for the largest proportion of Covid infections in the U.S., according to estimates from the Centers for Disease Control and Prevention.

The EG.5 coronavirus variant accounts for the largest share of Covid cases in the U.S., according to the CDC. New booster shots won't target it specifically.

Eris, made up an estimated 17.3pc of new cases

EG.5, the fast-spreading COVID subvariant, is now circulating in Canada as health officials across the world grapple to figure out its potential impact.

UNC Institute for Global Health and Infectious Diseases and critical care experts Dr. William Fischer Dr. David Wohl, in collaboration with UNC Hospitals colleagues, will lead a Regional Emerging Special Pathogen Treatment Center funded through the U.S. Department of Health and Human Services’ Administration for Strategic Preparedness and Response.